Review




Structured Review

Procell Inc human tnbc cell line bt549
Human Tnbc Cell Line Bt549, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pm42283962-55-1-9?v=Procell+Inc
Average 86 stars, based on 1 article reviews
human tnbc cell line bt549 - by Bioz Stars, 2026-07
86/100 stars

Images



Similar Products

99
ATCC human tnbc cell lines bt549
Human Tnbc Cell Lines Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pm40855211-146-0-17?v=ATCC
Average 99 stars, based on 1 article reviews
human tnbc cell lines bt549 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

86
Procell Inc human tnbc cell line bt549
Human Tnbc Cell Line Bt549, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pm42283962-55-1-9?v=Procell+Inc
Average 86 stars, based on 1 article reviews
human tnbc cell line bt549 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Procell Inc tnbc cell lines bt549
Tnbc Cell Lines Bt549, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pm41520847-61-11-20?v=Procell+Inc
Average 86 stars, based on 1 article reviews
tnbc cell lines bt549 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

99
ATCC triple negative breast cancer tnbc cell line bt549
Triple Negative Breast Cancer Tnbc Cell Line Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/10__1091_slash_mbc__e25___07___0340-244-2-14?v=ATCC
Average 99 stars, based on 1 article reviews
triple negative breast cancer tnbc cell line bt549 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC triple negative breast cancer tnbc cell lines bt549
YH395A inhibited breast cancer cell proliferation. (A) Breast cancer cell lines (MDA-MB-231, MDA-MB-468, <t>BT549,</t> SUM159, and BT-20), normal mammary epithelial cells (MCF-10 A), human gastric mucosal epithelial cells (GES-1), and human embryonic lung fibroblast cells (MRC-5) were treated with the indicated concentrations of YH395A or YR-290. After 96 h, SRB assay was performed. The bars indicate the mean ± SD. (B) Colony formation assays of breast cancer cells
Triple Negative Breast Cancer Tnbc Cell Lines Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pmc12235933-34-6-28?v=ATCC
Average 99 stars, based on 1 article reviews
triple negative breast cancer tnbc cell lines bt549 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Keygen Biotech tnbc cell lines bt549
YH395A inhibited breast cancer cell proliferation. (A) Breast cancer cell lines (MDA-MB-231, MDA-MB-468, <t>BT549,</t> SUM159, and BT-20), normal mammary epithelial cells (MCF-10 A), human gastric mucosal epithelial cells (GES-1), and human embryonic lung fibroblast cells (MRC-5) were treated with the indicated concentrations of YH395A or YR-290. After 96 h, SRB assay was performed. The bars indicate the mean ± SD. (B) Colony formation assays of breast cancer cells
Tnbc Cell Lines Bt549, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pm40221152-56-12-29?v=Keygen+Biotech
Average 90 stars, based on 1 article reviews
tnbc cell lines bt549 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
ATCC tnbc cell line bt549
Schematic diagram of survivin gene knockout using clustered regularly interspaced short palindromic repeats (CRISPR)-associated nuclease 9 (CRISPR/Cas9) in triple-negative breast cancer (TNBC) cell line <t>BT549.</t> EGFP: enhanced green fluorescent protein; PCR: polymerase chain reaction; sgRNA: single guide RNA
Tnbc Cell Line Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pmc11731936-57-0-8?v=ATCC
Average 99 stars, based on 1 article reviews
tnbc cell line bt549 - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC bt549 tnbc cell lines
FOXC1 is correlated with L1CAM, and its depletion leads to decreased L1CAM in TNBC cells. a Differences in L1CAM mRNA expression were examined between patients with a high ( n = 375) and low level ( n = 585) of FOXC1 mRNA. The mean was used for the cutoff value. b – c Two scatter plots were created to indicate the relation between FOXC1 and L1CAM mRNA expression in two public cohorts: TCGA and the Metastatic Breast Cancer Project, respectively (Pearson’s correlation coefficient r = 0.370, P < 0.001; r = 0.244, P = 0.002). d FOXC1 and L1CAM proteins were examined in four TNBC cell lines, with GAPDH serving as the loading control. e FOXC1 and L1CAM proteins were both down-regulated in <t>BT549-shFOXC1</t> cells (by two different shFOXC1 sequences: A1 and A3) compared to BT549-shNC. β-Actin served as the loading control. f Real-time PCR detected decreased transcriptional levels of FOXC1 and L1CAM in two BT549-shFOXC1 cell clones: BT549-shFOXC1-A1 and BT549-shFOXC1-A3, compared to BT549-shNC. NC: BT549-shFOXC1-NC. A1 and A3: knockdown of FOXC1 with two shRNA sequences: RNA1 and RNA3 in BT549 cells, respectively. * P < 0.05, ** P < 0.01, *** P < 0.001
Bt549 Tnbc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tnbc+cell+lines+bt549/pmc10959774-43-5-13?v=ATCC
Average 99 stars, based on 1 article reviews
bt549 tnbc cell lines - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

Image Search Results


YH395A inhibited breast cancer cell proliferation. (A) Breast cancer cell lines (MDA-MB-231, MDA-MB-468, BT549, SUM159, and BT-20), normal mammary epithelial cells (MCF-10 A), human gastric mucosal epithelial cells (GES-1), and human embryonic lung fibroblast cells (MRC-5) were treated with the indicated concentrations of YH395A or YR-290. After 96 h, SRB assay was performed. The bars indicate the mean ± SD. (B) Colony formation assays of breast cancer cells

Journal: Cell Communication and Signaling : CCS

Article Title: Artificial intelligence-driven discovery of YH395A: A novel TGFβR1 inhibitor with potent anti-tumor activity against triple-negative breast cancer

doi: 10.1186/s12964-025-02337-2

Figure Lengend Snippet: YH395A inhibited breast cancer cell proliferation. (A) Breast cancer cell lines (MDA-MB-231, MDA-MB-468, BT549, SUM159, and BT-20), normal mammary epithelial cells (MCF-10 A), human gastric mucosal epithelial cells (GES-1), and human embryonic lung fibroblast cells (MRC-5) were treated with the indicated concentrations of YH395A or YR-290. After 96 h, SRB assay was performed. The bars indicate the mean ± SD. (B) Colony formation assays of breast cancer cells

Article Snippet: The MCF-10 A, GES-1, MRC-5, and triple-negative breast cancer (TNBC) cell lines BT549 (RRID: CVCL_0062), MDA-MB-468 (RRID: CVCL_0419), BT-20 (RRID: CVCL_0169), and MDA-MB-231(RRID: CVCL_0063) were sourced from the American Type Culture Collection (ATCC, USA), while SUM159 cells were generously donated by Dr. Yuzhu Zhang (Guangdong Academy of Chinese Medicine, China).

Techniques: Sulforhodamine B Assay

Schematic diagram of survivin gene knockout using clustered regularly interspaced short palindromic repeats (CRISPR)-associated nuclease 9 (CRISPR/Cas9) in triple-negative breast cancer (TNBC) cell line BT549. EGFP: enhanced green fluorescent protein; PCR: polymerase chain reaction; sgRNA: single guide RNA

Journal: Narra J

Article Title: Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer

doi: 10.52225/narra.v4i3.1177

Figure Lengend Snippet: Schematic diagram of survivin gene knockout using clustered regularly interspaced short palindromic repeats (CRISPR)-associated nuclease 9 (CRISPR/Cas9) in triple-negative breast cancer (TNBC) cell line BT549. EGFP: enhanced green fluorescent protein; PCR: polymerase chain reaction; sgRNA: single guide RNA

Article Snippet: TNBC cell line BT549 was obtained from the American Type Culture Collection (ATCC) by the Laboratory of Experimental Pathology at the University of Tsukuba, Tsukuba, Japan.

Techniques: Gene Knockout, CRISPR, Polymerase Chain Reaction

Cleavage activity assay of single guide RNAs (sgRNAs) in BT549 cell line. Fluorescence intensity was quantified by using ImageJ software. Data was presented as mean±SD of fluorescence intensity ratio to cells without sgRNA transfection (control). *** Significantly different at p <0.001. A in the figure refers to sgRNA survin1/2 or survex A, while B refers to sgRNA survin1/2 or survex B.

Journal: Narra J

Article Title: Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer

doi: 10.52225/narra.v4i3.1177

Figure Lengend Snippet: Cleavage activity assay of single guide RNAs (sgRNAs) in BT549 cell line. Fluorescence intensity was quantified by using ImageJ software. Data was presented as mean±SD of fluorescence intensity ratio to cells without sgRNA transfection (control). *** Significantly different at p <0.001. A in the figure refers to sgRNA survin1/2 or survex A, while B refers to sgRNA survin1/2 or survex B.

Article Snippet: TNBC cell line BT549 was obtained from the American Type Culture Collection (ATCC) by the Laboratory of Experimental Pathology at the University of Tsukuba, Tsukuba, Japan.

Techniques: Activity Assay, Fluorescence, Software, Transfection, Control

Establishment of survivin knockout in BT549 cells using single sgRNA. (A) PCR amplification of wild-type and 6 clones (#1–#6) in exon 2 of survivin gene targeted region. (B) Alignments of wild-type cells and all clones’ sequences using forward primer (top) and reverse primer (bottom). (C) Survivin protein expression level in wild-type cells and all clones. Data was presented as mean±SD. *** Significantly different at p <0.001, where each clone was compared to wild-type cells as control.

Journal: Narra J

Article Title: Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer

doi: 10.52225/narra.v4i3.1177

Figure Lengend Snippet: Establishment of survivin knockout in BT549 cells using single sgRNA. (A) PCR amplification of wild-type and 6 clones (#1–#6) in exon 2 of survivin gene targeted region. (B) Alignments of wild-type cells and all clones’ sequences using forward primer (top) and reverse primer (bottom). (C) Survivin protein expression level in wild-type cells and all clones. Data was presented as mean±SD. *** Significantly different at p <0.001, where each clone was compared to wild-type cells as control.

Article Snippet: TNBC cell line BT549 was obtained from the American Type Culture Collection (ATCC) by the Laboratory of Experimental Pathology at the University of Tsukuba, Tsukuba, Japan.

Techniques: Knock-Out, Amplification, Clone Assay, Expressing, Control

Establishment of survivin knockout in BT549 cells using dual single guide RNAs (sgRNAs). (A) Schematic of primer design to detect wild-type and knockout of survivin gene. (B) Polymerase chain reaction (PCR) amplification of wild-type cells and six clones (#1–#6) in exon 2 of survivin gene targeted region. (C) Alignments of wild-type cells and all clones’ sequences show the success of survivin exon 2 deletion. A dash was used to symbolize the deletion of a single nucleotide. (D) Survivin protein expression level in wild-type cells and all clones. WT: wild type; KO: knockout; #1–#6: clone #1–#6.

Journal: Narra J

Article Title: Dual sgRNA-directed knockout survivin gene expression using CRISPR/Cas9 technology for editing survivin gene in triple-negative breast cancer

doi: 10.52225/narra.v4i3.1177

Figure Lengend Snippet: Establishment of survivin knockout in BT549 cells using dual single guide RNAs (sgRNAs). (A) Schematic of primer design to detect wild-type and knockout of survivin gene. (B) Polymerase chain reaction (PCR) amplification of wild-type cells and six clones (#1–#6) in exon 2 of survivin gene targeted region. (C) Alignments of wild-type cells and all clones’ sequences show the success of survivin exon 2 deletion. A dash was used to symbolize the deletion of a single nucleotide. (D) Survivin protein expression level in wild-type cells and all clones. WT: wild type; KO: knockout; #1–#6: clone #1–#6.

Article Snippet: TNBC cell line BT549 was obtained from the American Type Culture Collection (ATCC) by the Laboratory of Experimental Pathology at the University of Tsukuba, Tsukuba, Japan.

Techniques: Knock-Out, Polymerase Chain Reaction, Amplification, Clone Assay, Expressing

FOXC1 is correlated with L1CAM, and its depletion leads to decreased L1CAM in TNBC cells. a Differences in L1CAM mRNA expression were examined between patients with a high ( n = 375) and low level ( n = 585) of FOXC1 mRNA. The mean was used for the cutoff value. b – c Two scatter plots were created to indicate the relation between FOXC1 and L1CAM mRNA expression in two public cohorts: TCGA and the Metastatic Breast Cancer Project, respectively (Pearson’s correlation coefficient r = 0.370, P < 0.001; r = 0.244, P = 0.002). d FOXC1 and L1CAM proteins were examined in four TNBC cell lines, with GAPDH serving as the loading control. e FOXC1 and L1CAM proteins were both down-regulated in BT549-shFOXC1 cells (by two different shFOXC1 sequences: A1 and A3) compared to BT549-shNC. β-Actin served as the loading control. f Real-time PCR detected decreased transcriptional levels of FOXC1 and L1CAM in two BT549-shFOXC1 cell clones: BT549-shFOXC1-A1 and BT549-shFOXC1-A3, compared to BT549-shNC. NC: BT549-shFOXC1-NC. A1 and A3: knockdown of FOXC1 with two shRNA sequences: RNA1 and RNA3 in BT549 cells, respectively. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Breast Cancer Research and Treatment

Article Title: Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression

doi: 10.1007/s10549-023-07177-7

Figure Lengend Snippet: FOXC1 is correlated with L1CAM, and its depletion leads to decreased L1CAM in TNBC cells. a Differences in L1CAM mRNA expression were examined between patients with a high ( n = 375) and low level ( n = 585) of FOXC1 mRNA. The mean was used for the cutoff value. b – c Two scatter plots were created to indicate the relation between FOXC1 and L1CAM mRNA expression in two public cohorts: TCGA and the Metastatic Breast Cancer Project, respectively (Pearson’s correlation coefficient r = 0.370, P < 0.001; r = 0.244, P = 0.002). d FOXC1 and L1CAM proteins were examined in four TNBC cell lines, with GAPDH serving as the loading control. e FOXC1 and L1CAM proteins were both down-regulated in BT549-shFOXC1 cells (by two different shFOXC1 sequences: A1 and A3) compared to BT549-shNC. β-Actin served as the loading control. f Real-time PCR detected decreased transcriptional levels of FOXC1 and L1CAM in two BT549-shFOXC1 cell clones: BT549-shFOXC1-A1 and BT549-shFOXC1-A3, compared to BT549-shNC. NC: BT549-shFOXC1-NC. A1 and A3: knockdown of FOXC1 with two shRNA sequences: RNA1 and RNA3 in BT549 cells, respectively. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The SUM149, HCC1937, MDA-MB-231 and BT549 TNBC cell lines were obtained from the ATCC (American Type Culture Collection, Manassas, VA, USA).

Techniques: Expressing, Control, Real-time Polymerase Chain Reaction, Clone Assay, Knockdown, shRNA

Inhibition of L1CAM suppresses expression of FOXC1 proteins, cell proliferation, invasion and migration. a Down regulation of both L1CAM and FOXC1 proteins was detected in BT549-siL1CAM cells. GAPDH served as the loading control. b Real-time PCR detected a considerable decrease of L1CAM mRNA, but only a slight decrease of FOXC1 mRNA in BT549-siL1CAM cells. c CCK-8 assay showed L1CAM knockdown decreased the capacity of cell proliferation. d Cell migration and invasion were impaired after L1CAM knockdown in BT549 cells. e L1CAM knockdown suppressed BT549 cell migration in a wound healing assay. NC: negative control, siL1CAM: a small interfering RNA used to knockdown L1CAM mRNA in BT549 cells. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Breast Cancer Research and Treatment

Article Title: Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression

doi: 10.1007/s10549-023-07177-7

Figure Lengend Snippet: Inhibition of L1CAM suppresses expression of FOXC1 proteins, cell proliferation, invasion and migration. a Down regulation of both L1CAM and FOXC1 proteins was detected in BT549-siL1CAM cells. GAPDH served as the loading control. b Real-time PCR detected a considerable decrease of L1CAM mRNA, but only a slight decrease of FOXC1 mRNA in BT549-siL1CAM cells. c CCK-8 assay showed L1CAM knockdown decreased the capacity of cell proliferation. d Cell migration and invasion were impaired after L1CAM knockdown in BT549 cells. e L1CAM knockdown suppressed BT549 cell migration in a wound healing assay. NC: negative control, siL1CAM: a small interfering RNA used to knockdown L1CAM mRNA in BT549 cells. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The SUM149, HCC1937, MDA-MB-231 and BT549 TNBC cell lines were obtained from the ATCC (American Type Culture Collection, Manassas, VA, USA).

Techniques: Inhibition, Expressing, Migration, Control, Real-time Polymerase Chain Reaction, CCK-8 Assay, Knockdown, Wound Healing Assay, Negative Control, Small Interfering RNA

Overexpression of L1CAM induces expression of FOXC1 proteins, cell proliferation, cell invasion and migration. a Western blotting showed L1CAM and FOXC1 proteins after overexpression of L1CAM in BT549-shFOXC1-A1 and BT549-shFOXC1-A3, i.e., BT549-shFOXC1-L1CAM-OA1 and BT549-shFOXC1-L1CAM-OA3. Their controls were represented as BT549-shFOXC1-NA1 and BT549-shFOXC1-NA3. β-Actin served as the loading control. b – c Real-time PCR showed the relative mRNA expression of L1CAM and FOXC1 after overexpressing L1CAM in BT549-shFOXC1 cells. d – e CCK-8 assays showed the effect of L1CAM overexpression on cell proliferation in BT549-shFOXC1-L1CAM. f – g Cell migration and invasion were evaluated after overexpressing L1CAM in BT549-shFOXC1 cells. h–i Upregulation of L1CAM in BT549-shFOXC1 cells enhanced cell migration in vitro wound healing assays. NA1: BT549-shFOXC1-A1 transfected with empty vector control. OA1: BT549-shFOXC1-A1 cells overexpressing L1CAM. NA3: BT549-shFOXC1-A3 transfected with empty vector control. OA3: BT549-shFOXC1-A3 cells overexpressing L1CAM. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Breast Cancer Research and Treatment

Article Title: Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression

doi: 10.1007/s10549-023-07177-7

Figure Lengend Snippet: Overexpression of L1CAM induces expression of FOXC1 proteins, cell proliferation, cell invasion and migration. a Western blotting showed L1CAM and FOXC1 proteins after overexpression of L1CAM in BT549-shFOXC1-A1 and BT549-shFOXC1-A3, i.e., BT549-shFOXC1-L1CAM-OA1 and BT549-shFOXC1-L1CAM-OA3. Their controls were represented as BT549-shFOXC1-NA1 and BT549-shFOXC1-NA3. β-Actin served as the loading control. b – c Real-time PCR showed the relative mRNA expression of L1CAM and FOXC1 after overexpressing L1CAM in BT549-shFOXC1 cells. d – e CCK-8 assays showed the effect of L1CAM overexpression on cell proliferation in BT549-shFOXC1-L1CAM. f – g Cell migration and invasion were evaluated after overexpressing L1CAM in BT549-shFOXC1 cells. h–i Upregulation of L1CAM in BT549-shFOXC1 cells enhanced cell migration in vitro wound healing assays. NA1: BT549-shFOXC1-A1 transfected with empty vector control. OA1: BT549-shFOXC1-A1 cells overexpressing L1CAM. NA3: BT549-shFOXC1-A3 transfected with empty vector control. OA3: BT549-shFOXC1-A3 cells overexpressing L1CAM. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The SUM149, HCC1937, MDA-MB-231 and BT549 TNBC cell lines were obtained from the ATCC (American Type Culture Collection, Manassas, VA, USA).

Techniques: Over Expression, Expressing, Migration, Western Blot, Control, Real-time Polymerase Chain Reaction, CCK-8 Assay, In Vitro, Transfection, Plasmid Preparation